Mutations in the TREM2 gene are associated with an increased risk of AD development, and its absence accelerates the accumulation of AB plaques and neuronal loss, implying that the Trem2-dependent DAM phenotype is likely to mitigate the disease progression. This evidence concerns the gene TREM2 and Alzheimer disease.